GENENET TECHNOLOGY (UK) LIMITED

Company Registration Number:
13145388 (England and Wales)

Unaudited abridged accounts for the year ended 05 April 2026

Period of accounts

Start date: 06 April 2025

End date: 05 April 2026

GENENET TECHNOLOGY (UK) LIMITED

Contents of the Financial Statements

for the Period Ended 05 April 2026

Balance sheet
Notes

GENENET TECHNOLOGY (UK) LIMITED

Balance sheet

As at 05 April 2026


Notes
2026
2025


£
£
Fixed assets
Intangible assets: 3 5,413 6,486
Tangible assets: 4 6,637 4,399
Total fixed assets: 12,050 10,885
Current assets
Cash at bank and in hand: 5,863 477
Total current assets: 5,863 477
Creditors: amounts falling due within one year:   (375,459) (300,353)
Net current assets (liabilities): (369,596) (299,876)
Total assets less current liabilities: (357,546) (288,991)
Total net assets (liabilities): (357,546) (288,991)
Capital and reserves
Called up share capital: 100 100
Profit and loss account: (357,646) (289,091)
Shareholders funds: (357,546) (288,991)

The notes form part of these financial statements

GENENET TECHNOLOGY (UK) LIMITED

Balance sheet statements

For the year ending 5 April 2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 24 April 2026
and signed on behalf of the board by:

Name: C Seak
Status: Director

The notes form part of these financial statements

GENENET TECHNOLOGY (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 05 April 2026

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

GENENET TECHNOLOGY (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 05 April 2026

2. Employees

2026 2025
Average number of employees during the period 3 4

GENENET TECHNOLOGY (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 05 April 2026

3. Intangible Assets

Total
Cost £
At 06 April 2025 10,728
At 05 April 2026 10,728
Amortisation
At 06 April 2025 4,242
Charge for year 1,073
At 05 April 2026 5,315
Net book value
At 05 April 2026 5,413
At 05 April 2025 6,486

GENENET TECHNOLOGY (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 05 April 2026

4. Tangible Assets

Total
Cost £
At 06 April 2025 15,040
Additions 4,856
At 05 April 2026 19,896
Depreciation
At 06 April 2025 10,641
Charge for year 2,618
At 05 April 2026 13,259
Net book value
At 05 April 2026 6,637
At 05 April 2025 4,399